Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive neoplasms that commonly occur in patients with neurofibromatosis type 1 (NF1). Effective chemotherapy is not available. To characterize a therapeutic target for treatment, we investigated the role of cellular retinoic acid binding protein 2 (CRABP2) in MPNST in vitro. CRABP2 is a transcriptional co-activator of retinoic acid signaling. Although overexpression of CRABP2 is described in several cancers, it has not yet been studied in MPNSTs. We investigated CRABP2 expression in cultured Schwann cells and formalin-fixed, paraffin-embedded specimens of human peripheral nerve sheath tumors. A transient knockdown of CRABP2 was established in human NF1-associated MPNST cell lines (S462, T265, NSF1), and functional effects on viability, proliferation, apoptosis, and cytotoxicity were monitored. Finally, a 45-pathway reporter assay was performed in knockdown cells. Expression of CRABP2 was found in epithelium, fibroblasts, and tumor Schwann cells of skin, neurofibromas, and MPNSTs. In contrast, normal skin Schwann cells (NF1(+/-), NF1(-/-)) did not express CRABP2. In the absence of retinoic acid, MPNST cells depleted of CRABP2 had reduced viability and proliferation, induc...Continue Reading
References
Jan 1, 1992·Dermatology : International Journal for Clinical and Investigative Dermatology·G SiegenthalerJ H Saurat
Jun 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·M DonovanU Eriksson
Jul 1, 1995·Experimental Cell Research·S P SiM Peacocke
Apr 1, 1995·Experimental Dermatology·M S EllerB A Gilchrest
Nov 1, 1996·Endocrinology·W L ZhengD E Ong
Jan 1, 1997·Biology of Reproduction·S A WardlawD E Ong
Aug 15, 1998·Biochemical and Biophysical Research Communications·M KreutzS W Krause
Nov 24, 1998·European Journal of Biochemistry·M YamamotoP McCaffery
Aug 14, 1999·The Journal of Biological Chemistry·D DongN Noy
Dec 15, 2000·Human Molecular Genetics·F BertucciC Nguyen
Jul 4, 2002·Fertility and Sterility·John C M TsibrisWilliam N Spellacy
Mar 21, 2003·Journal of Proteome Research·Yetrib HathoutCatherine Fenselau
Sep 6, 2003·The European Journal of Neuroscience·Nina ZhelyaznikJörg Mey
Jun 23, 2004·Neurobiology of Disease·Silke FrahmLan Kluwe
Sep 17, 2005·Cancer Research·Leslie J Donato, Noa Noy
Dec 17, 2005·Carcinogenesis·Nikola HoltkampAndreas von Deimling
Jan 24, 2006·Neuron Glia Biology·Philip R LeeR Douglas Fields
Apr 8, 2006·Physiological Reviews·Béatrice DesvergneWalter Wahli
Aug 17, 2006·Cancer Research·Anu GuptaJawhar Rawwas
Sep 19, 2006·Journal of Molecular Biology·Soheila VaezeslamiJames H Geiger
May 22, 2007·Cell·Liliane Michalik, Walter Wahli
Sep 21, 2007·Lipids·Friedhelm SchroederAnn B Kier
Dec 7, 2007·The European Journal of Neuroscience·Benjamin DieplingerIlja Vietor
Sep 23, 2008·Glia·Steven L Carroll, Nancy Ratner
Oct 29, 2008·Experimental Cell Research·Anu GuptaBryan R G Williams
Feb 6, 2009·Annals of Surgical Oncology·Eric J DozoisDavid W Larson
Aug 24, 2011·Annals of Surgical Oncology·Chee-Chee H StuckyNabil Wasif
Dec 14, 2011·Molecular Oncology·Yuan-Shan FuJia Liu
Feb 11, 2012·Cancer Science·Atsuhiko ToyamaTaka-Aki Sato
Aug 11, 2012·Annals of Surgical Oncology·Jennifer LaFeminaSamuel Singer
Apr 27, 2013·BMC Medicine·Su-Jin ParkAndreas Kurtz
Apr 2, 2014·Molecular and Cellular Biology·Amanda C VreelandNoa Noy
Jun 16, 2015·Oncogene·H LiJ Wu
Jan 27, 2017·Genes, Chromosomes & Cancer·Pierre SohierMeena Upadhyaya
Citations
Apr 19, 2018·Expert Opinion on Therapeutic Targets·James A Walker, Meena Upadhyaya
Nov 14, 2017·PloS One·Susan Fischer-HuchzermeyerAnja Harder
Feb 6, 2020·Current Protein & Peptide Science·Xiaoyang JiaoEnmin Li
Jun 9, 2018·Scientific Reports·Nerea MosqueraCarmen Conde
Jul 30, 2018·BMC Research Notes·Susan Fischer-HuchzermeyerAnja Harder
Jul 9, 2020·Cancer Management and Research·Wei XuMing Zhong
Oct 1, 2020·Food Science & Nutrition·Xinhong LiuXin Zhao
Jan 31, 2019·Scientific Reports·Jun-I WuLu-Hai Wang